Bevacizumab (B) plus Everolimus (E) in Refractory Metastatic Colorectal Cancer
Bevacizumab (B) plus Everolimus (E) in Refractory Metastatic Colorectal Cancer. K. E. Bullock 1 , H. I. Hurwitz 1 , H. E. Uronis 1 , M. A. Morse 1 , G. C. Blobe 1 , S. D. Hsu 1 , S.Y. Zafar 1 , L. A. Howard 1 , I. P. Altomare 1 , J.C. Bendell 2.
160 views • 1 slides